Exponent (NASDAQ:EXPO) Posts Quarterly Earnings Results
Exponent (NASDAQ:EXPO) announced its earnings results on Thursday. The business services provider reported $0.31 EPS for the quarter, topping the consensus estimate of $0.22 by $0.09, MarketWatch Earnings reports. Exponent had a net margin of 19.87% and a return on equity of 23.68%. The company had revenue of $87.86 million during the quarter, compared to analysts’ expectations of $85.11 million.
Shares of NASDAQ EXPO traded up $0.61 during mid-day trading on Friday, reaching $84.06. The company had a trading volume of 420,743 shares, compared to its average volume of 186,028. The stock has a fifty day moving average of $78.81 and a two-hundred day moving average of $73.63. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.81 and a current ratio of 3.81. The company has a market capitalization of $4.33 billion, a price-to-earnings ratio of 55.30 and a beta of 0.26. Exponent has a 12-month low of $58.03 and a 12-month high of $84.34.
In other news, Director Paul R. Johnston sold 8,352 shares of Exponent stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $76.55, for a total value of $639,345.60. Following the transaction, the director now owns 71,979 shares of the company’s stock, valued at $5,509,992.45. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Paul R. Johnston sold 5,648 shares of Exponent stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $74.20, for a total transaction of $419,081.60. Following the completion of the transaction, the director now directly owns 69,275 shares in the company, valued at approximately $5,140,205. The disclosure for this sale can be found here. Insiders sold 60,070 shares of company stock valued at $4,545,523 over the last three months. 2.20% of the stock is owned by insiders.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Further Reading: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.